• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创建和评估用于基因组手术的精确 CRISPR-Cas9 手术刀。

Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

机构信息

Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

出版信息

Nat Methods. 2016 Jan;13(1):41-50. doi: 10.1038/nmeth.3684.

DOI:10.1038/nmeth.3684
PMID:26716561
Abstract

The simplicity of site-specific genome targeting by type II clustered, regularly interspaced, short palindromic repeat (CRISPR)-Cas9 nucleases, along with their robust activity profile, has changed the landscape of genome editing. These favorable properties have made the CRISPR-Cas9 system the technology of choice for sequence-specific modifications in vertebrate systems. For many applications, whether the focus is on basic science investigations or therapeutic efficacy, activity and precision are important considerations when one is choosing a nuclease platform, target site and delivery method. Here we review recent methods for increasing the activity and accuracy of Cas9 and assessing the extent of off-target cleavage events.

摘要

由 II 型簇状、规律间隔、短回文重复(CRISPR)-Cas9 核酸酶介导的靶向特定基因的方法具有简单性,再加上其强大的活性特征,改变了基因组编辑的格局。这些有利的特性使得 CRISPR-Cas9 系统成为脊椎动物系统中序列特异性修饰的首选技术。对于许多应用,无论是关注基础科学研究还是治疗效果,在选择核酸酶平台、靶位点和递送方法时,活性和精度都是重要的考虑因素。在这里,我们综述了提高 Cas9 活性和准确性的最新方法,并评估了脱靶切割事件的程度。

相似文献

1
Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.创建和评估用于基因组手术的精确 CRISPR-Cas9 手术刀。
Nat Methods. 2016 Jan;13(1):41-50. doi: 10.1038/nmeth.3684.
2
CRISPR/Cas9 for genome editing: progress, implications and challenges.用于基因组编辑的CRISPR/Cas9:进展、影响及挑战
Hum Mol Genet. 2014 Sep 15;23(R1):R40-6. doi: 10.1093/hmg/ddu125. Epub 2014 Mar 20.
3
Therapeutic applications of CRISPR RNA-guided genome editing.CRISPR RNA 引导的基因组编辑的治疗应用。
Brief Funct Genomics. 2017 Jan;16(1):38-45. doi: 10.1093/bfgp/elw032. Epub 2016 Aug 25.
4
RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?CRISPR 系统中的 RNA 依赖性 DNA 内切酶 Cas9:基因组编辑的圣杯?
Trends Microbiol. 2013 Nov;21(11):562-7. doi: 10.1016/j.tim.2013.09.001. Epub 2013 Oct 1.
5
Genome editing using Cas9 nickases.使用Cas9切口酶进行基因组编辑。
Methods Enzymol. 2014;546:161-74. doi: 10.1016/B978-0-12-801185-0.00008-8.
6
Application of CRISPR/Cas9 genome editing to the study and treatment of disease.CRISPR/Cas9 基因组编辑在疾病研究和治疗中的应用。
Arch Toxicol. 2015 Jul;89(7):1023-34. doi: 10.1007/s00204-015-1504-y. Epub 2015 Apr 1.
7
Genome modification by CRISPR/Cas9.利用CRISPR/Cas9进行基因组编辑。
FEBS J. 2014 Dec;281(23):5186-93. doi: 10.1111/febs.13110. Epub 2014 Nov 7.
8
CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.CRISPR/Cas9系统作为一种创新的基因工程工具:序列特异性和递送方法的改进
Biochim Biophys Acta. 2015 Dec;1856(2):234-43. doi: 10.1016/j.bbcan.2015.09.003. Epub 2015 Nov 11.
9
RNA-guided genome editing in plants using a CRISPR-Cas system.利用 CRISPR-Cas 系统进行植物的 RNA 引导基因组编辑。
Mol Plant. 2013 Nov;6(6):1975-83. doi: 10.1093/mp/sst119. Epub 2013 Aug 17.
10
The application of genome editing in studying hearing loss.基因组编辑在听力损失研究中的应用。
Hear Res. 2015 Sep;327:102-8. doi: 10.1016/j.heares.2015.04.016. Epub 2015 May 15.

引用本文的文献

1
Elf1 Deficiency Impairs Macrophage Development in Zebrafish Model Organism.Elf1基因缺陷损害斑马鱼模式生物中的巨噬细胞发育。
Int J Mol Sci. 2025 Mar 12;26(6):2537. doi: 10.3390/ijms26062537.
2
Genome engineering with Cas9 and AAV repair templates, successes and pitfalls.利用Cas9和腺相关病毒修复模板进行基因组工程:成功与陷阱
Mamm Genome. 2025 Jan 13. doi: 10.1007/s00335-024-10099-4.
3
Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.设计表观基因组编辑工具:考虑生化特性和基因座特异性。

本文引用的文献

1
DNA-binding-domain fusions enhance the targeting range and precision of Cas9.DNA结合结构域融合增强了Cas9的靶向范围和精准度。
Nat Methods. 2015 Dec;12(12):1150-6. doi: 10.1038/nmeth.3624. Epub 2015 Oct 19.
2
Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.Cpf1是2类CRISPR-Cas系统中的一种单RNA引导的内切核酸酶。
Cell. 2015 Oct 22;163(3):759-71. doi: 10.1016/j.cell.2015.09.038. Epub 2015 Sep 25.
3
An updated evolutionary classification of CRISPR-Cas systems.CRISPR-Cas系统的最新进化分类
Methods Mol Biol. 2024;2842:23-55. doi: 10.1007/978-1-0716-4051-7_2.
4
Unexpected mutations occurred in CRISPR/Cas9 edited Drosophila analyzed by deeply whole genomic sequencing.通过深度全基因组测序分析发现,在经CRISPR/Cas9编辑的果蝇中出现了意外突变。
Heliyon. 2024 Mar 30;10(7):e29061. doi: 10.1016/j.heliyon.2024.e29061. eCollection 2024 Apr 15.
5
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases.用于神经退行性疾病的重组腺相关病毒载体的研究进展
Biomedicines. 2023 Oct 8;11(10):2725. doi: 10.3390/biomedicines11102725.
6
Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes.通过在 DMD 患者特异性 iPSCs 和心肌细胞中靶向添加外显子实现全长 dystrophin 的修复。
Int J Mol Sci. 2022 Aug 16;23(16):9176. doi: 10.3390/ijms23169176.
7
Blunted Amphetamine-induced Reinforcing Behaviors and Transporter Downregulation in Knock-in Mice Carrying Alanine Mutations at Threonine-258 and Serine-259 of Norepinephrine Transporter.携带去甲肾上腺素转运蛋白第 258 位苏氨酸和第 259 位丝氨酸丙氨酸突变的敲入小鼠中,安非他命诱导的强化行为和转运体下调变钝。
J Mol Neurosci. 2022 Sep;72(9):1965-1976. doi: 10.1007/s12031-022-01988-x. Epub 2022 Jul 19.
8
The Progression of Treatment for Refractory Hypercholesterolemia: Focus on the Prospect of Gene Therapy.难治性高胆固醇血症的治疗进展:聚焦基因治疗前景
Front Genet. 2022 Jun 9;13:911429. doi: 10.3389/fgene.2022.911429. eCollection 2022.
9
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy.基因编辑中的脱靶分析以及CRISPR/Cas9在HIV-1治疗临床转化中的应用
Front Genome Ed. 2021 Aug 17;3:673022. doi: 10.3389/fgeed.2021.673022. eCollection 2021.
10
Base editing-coupled survival screening enabled high-sensitive analysis of PAM compatibility and finding of the new possible off-target.碱基编辑偶联存活筛选实现了对PAM兼容性的高灵敏度分析并发现了新的潜在脱靶位点。
iScience. 2021 Jun 24;24(7):102769. doi: 10.1016/j.isci.2021.102769. eCollection 2021 Jul 23.
Nat Rev Microbiol. 2015 Nov;13(11):722-36. doi: 10.1038/nrmicro3569. Epub 2015 Sep 28.
4
Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage.RNA 引导的内切酶 Cas9 的结构和特异性在 DNA 检测、靶标结合和切割过程中的作用。
Nucleic Acids Res. 2015 Oct 15;43(18):8924-41. doi: 10.1093/nar/gkv892. Epub 2015 Sep 17.
5
CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo.CRISPRscan:设计用于体内CRISPR-Cas9靶向的高效单向导RNA
Nat Methods. 2015 Oct;12(10):982-8. doi: 10.1038/nmeth.3543. Epub 2015 Aug 31.
6
In vivo genome editing of the albumin locus as a platform for protein replacement therapy.作为蛋白质替代疗法平台的白蛋白基因座体内基因组编辑。
Blood. 2015 Oct 8;126(15):1777-84. doi: 10.1182/blood-2014-12-615492. Epub 2015 Aug 21.
7
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.使用Cas9核糖核蛋白生成敲入型原代人T细胞。
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10437-42. doi: 10.1073/pnas.1512503112. Epub 2015 Jul 27.
8
Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9.利用 CRISPR-Cas9 技术对血友病 A 患者诱导多能干细胞中大型凝血因子 VIII 基因染色体倒位进行功能矫正。
Cell Stem Cell. 2015 Aug 6;17(2):213-20. doi: 10.1016/j.stem.2015.07.001. Epub 2015 Jul 23.
9
A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks.在原代免疫细胞中进行全基因组CRISPR筛选以剖析调控网络
Cell. 2015 Jul 30;162(3):675-86. doi: 10.1016/j.cell.2015.06.059. Epub 2015 Jul 16.
10
Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach.通过文库对文库的方法解析CRISPR-Cas9基因组编辑参数。
Nat Methods. 2015 Sep;12(9):823-6. doi: 10.1038/nmeth.3473. Epub 2015 Jul 13.